STOCK TITAN

RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities

(Moderate)
(Neutral)
Tags

RadNet (NASDAQ: RDNT) plans to secure a $200 million incremental term loan under an amendment to its First Lien Credit and Guaranty Agreement. The new loan would form part of its existing term loan and mature on April 18, 2031.

Proceeds are expected to support acquisitions, organic expansion, health system partnerships and general corporate purposes, giving RadNet added flexibility for strategic growth. Completion of the loan transaction is subject to customary market and other conditions.

Loading...
Loading translation...

Positive

  • $200 million proposed incremental term loan to expand liquidity
  • New loan would share April 18, 2031 maturity with existing term loan
  • Proceeds expected for acquisitions and organic expansion initiatives
  • Funding aimed at health system partnerships and general corporate purposes
  • Management positions financing as proactive support for future growth

Negative

  • Transaction is only proposed and subject to market and other conditions
  • Additional $200 million term loan would increase RadNet’s debt load
  • Ability to consummate loan may be affected by economic and credit conditions
  • Forward‑looking execution risks highlighted, including regulation and pandemics

News Market Reaction – RDNT

-4.49%
-4.49% Session close to close

In the Jun 3 session, RDNT declined 4.49%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines RadNet’s plan to add a $200 million incremental term loan maturing in 203...
Analysis

This announcement outlines RadNet’s plan to add a $200 million incremental term loan maturing in 2031 to support acquisitions, organic expansion, and health system partnerships. It follows record Q1 2026 revenue of $575.6 million and raised guidance, reinforcing a growth-focused trajectory. Investors may watch for final loan terms, changes in total debt, and subsequent deployment of proceeds across the 435-center network and DeepHealth AI platforms.

Key Figures

Proposed incremental term loan: $200 million Q1 2026 revenue: $575.6 million Net loss Q1 2026: $33.5 million +5 more
8 metrics
Proposed incremental term loan $200 million Aggregate principal amount of Proposed 2026 Incremental Term Loan
Q1 2026 revenue $575.6 million Total service revenue reported in Q1 2026 10-Q
Net loss Q1 2026 $33.5 million Net loss attributable to common stockholders in Q1 2026 10-Q
Loss per share Q1 2026 $0.43 Basic and diluted loss per share in Q1 2026 10-Q
Debt obligations $1.09 billion Total debt obligations as of March 31, 2026 per 10-Q
Cash balance $455.3 million Cash at quarter-end reported in 8-K for Q1 2026
2026 revenue guidance $2,355–$2,405 million Imaging Center segment revenue guidance range raised in 8-K
Imaging centers 435 centers Number of imaging centers operated as of March 31, 2026

Historical Context

5 past events · Latest: May 28 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
May 28 Investor outreach Neutral +2.7% Announcement of public Men’s Health webinar featuring leading radiologists.
May 10 Earnings and guidance Positive -3.9% Record Q1 2026 results with higher revenue, EBITDA and raised guidance ranges.
Apr 30 Partnership expansion Positive +0.5% Multi-site joint venture in Boise adding five imaging centers and new revenue.
Apr 28 Earnings call notice Neutral +0.2% Scheduling of Q1 2026 results conference call for May 11, 2026.
Apr 16 AI collaboration Positive +0.5% GE HealthCare expanding global access to DeepHealth AI breast screening tools.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has generally seen modestly positive reactions, but a strong earnings beat with raised guidance on May 10, 2026 coincided with a negative move, indicating occasional sell-the-news behavior.

Recent Company History

Over the last few months, RadNet has combined operational expansion with strong financial growth. Record Q1 2026 results on May 10 showed revenue of $575.6 million and raised 2026 guidance, though shares fell 3.94%. Partnerships in Idaho and expanded AI collaboration with GE HealthCare highlighted strategic growth. Today’s proposed $200 million incremental term loan aligns with this expansion strategy by targeting acquisitions and organic initiatives.

Key Terms

term loan, first lien credit and guaranty agreement, forward-looking statements
3 terms
term loan financial
"it seeks to secure an incremental term loan in the aggregate principal amount"
A term loan is a type of loan that is borrowed for a set period of time, with a fixed schedule for repaying the money, usually in regular payments. It matters to investors because it represents a company's borrowing costs and financial stability; reliable repayment of these loans can indicate strong financial health, while difficulties may signal potential risks.
first lien credit and guaranty agreement financial
"to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended"
A first lien credit and guaranty agreement is a loan contract that gives certain lenders the top legal claim (first lien) on specified assets and includes promises from one or more parties to guarantee repayment. Think of it like a mortgage plus a cosigner: the lender has first dibs on collateral if the borrower defaults, and guarantors back the debt. Investors watch these terms because they determine who gets paid first and how well lenders are protected in a bankruptcy or distress scenario.
forward-looking statements regulatory
"This press release contains “forward-looking statements” within the meaning of the safe harbor"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LOS ANGELES, June 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT(“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of outpatient imaging centers and a premier developer of radiology digital health solutions, today announced that it seeks to secure an incremental term loan in the aggregate principal amount of $200 million (the “Proposed 2026 Incremental Term Loan”) pursuant to a proposed amendment (the “Proposed Amendment”) to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended (the “Existing Credit Agreement” and, the transaction, the “Loan Transaction”).

If consummated, the Proposed 2026 Incremental Term Loan would be added to and form a part of the existing term loan under the Existing Credit Agreement (the “Existing Term Loan”). The Proposed 2026 Incremental Term Loan would mature on April 18, 2031—coincident with the maturity date of the Existing Term Loan under the Existing Credit Agreement.

The proceeds of the Proposed 2026 Incremental Term Loan are expected to be used to finance future acquisitions, organic expansion initiatives, health system partnerships and for other general corporate purposes, providing RadNet with additional flexibility to pursue strategic growth opportunities across its national imaging center network and technology platforms.

Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, commented: “We are seeking to opportunistically and proactively raise additional funds to support the future growth of our business. While the consummation of the Loan Transaction is subject to customary market and other conditions, if successful, we expect to consummate the Loan Transaction towards the middle of this month.”

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities of RadNet and shall not constitute an offer, solicitation or sale in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration and qualification under the securities laws of such state or jurisdiction.

About RadNet, Inc.

RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet’s imaging center markets include Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under its DeepHealth brand and teleradiology professional services and other related products and services to customers in the diagnostic imaging industry globally. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. Learn more at radnet.com.

Forward Looking Statements 

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are expressions of RadNet’s current beliefs, expectations and assumptions regarding the future of RadNet’s business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements in this press release include, among others, statements RadNet makes regarding its ability to reach mutually agreeable terms for the Proposed Amendment, to amend the Existing Credit Agreement and to consummate the Loan Transaction; the timing and ultimate terms of any such amendment and consummation; and its expected use of proceeds from the Loan Transaction.

Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of RadNet’s control, which may cause actual events to be materially different from those expressed or implied herein. Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could impact RadNet’s ability to amend the Existing Credit Agreement and consummate the Loan Transaction include, among others, the following:

  • a decline or anticipated decline in RadNet’s operating results or financial position, as a result of operational issues, regulatory changes, litigation, casualty loss, or other factors;
  • changes in general economic conditions nationally and regionally in the markets in which RadNet operates;
  • volatility in interest and exchange rates, or credit markets;
  • the occurrence of hostilities, political instability or catastrophic events; and
  • the emergence or reemergence of and effects related to future pandemics, epidemics and infectious diseases.

Any forward-looking statement contained in this press release is based on information currently available to RadNet and speaks only as of the date on which it is made. RadNet undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that it may make from time to time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable law.

Contact:
RadNet, Inc.
Mark Stolper, 310-445-2800
Executive Vice President and Chief Financial Officer


FAQ

What did RadNet (NASDAQ: RDNT) announce on June 3, 2026?

RadNet announced plans for a proposed $200 million incremental term loan. According to RadNet, the loan would amend its existing First Lien Credit and Guaranty Agreement and become part of its current term loan structure, subject to market and other conditions.

How will RadNet use the proceeds from the proposed $200 million RDNT term loan?

RadNet expects to use proceeds for acquisitions, organic expansion and partnerships. According to RadNet, funds are intended to finance future acquisitions, growth initiatives, health system partnerships and other general corporate purposes across its national imaging center network and technology platforms.

When would the proposed RadNet (RDNT) incremental term loan mature?

The proposed incremental term loan would mature on April 18, 2031. According to RadNet, this maturity date matches the existing term loan under its current First Lien Credit and Guaranty Agreement, keeping the overall credit facility on a unified schedule.

Is the $200 million RadNet incremental term loan transaction guaranteed to close?

The loan transaction is not guaranteed and remains subject to conditions. According to RadNet, consummation depends on reaching mutually agreeable terms, amending the existing credit agreement and market and other customary conditions that could affect timing or completion.

What risks could affect RadNet’s ability to complete the $200 million RDNT loan?

Completion could be affected by operating performance and broader economic forces. According to RadNet, key risks include declines in results, regulatory changes, litigation, credit market volatility, political instability, catastrophic events and the emergence or reemergence of pandemics and infectious diseases.

How does the proposed RadNet term loan support RDNT’s growth strategy?

The proposed financing is intended to fund strategic growth initiatives. According to RadNet, additional capital would support acquisitions, organic expansion and health system partnerships, aiming to enhance flexibility for scaling its outpatient imaging network and radiology digital health platforms.